(Q34254903)

31 July 2017

title

Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study (English)

1 reference

31 July 2017

0 references

M Harrow

1

1 reference

31 July 2017

T H Jobe

series ordinal

2

1 reference

31 July 2017

R N Faull

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

17 February 2012

1 reference

31 July 2017

published in

Psychological Medicine

1 reference

31 July 2017

volume

42

1 reference

31 July 2017

issue

10

1 reference

31 July 2017

page(s)

2145-2155

1 reference

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

Two-year outcome in first-episode psychosis treated according to an integrated model. Is immediate neuroleptisation always needed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

Reasoning about the optimal duration of prophylactic antipsychotic medication in schizophrenia: evidence and arguments

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

Endophenotype: a conceptual analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

Neurocognition in schizophrenia: a 20-year multi–follow-up of the course of processing speed and stored knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

At issue: predicting drug-free treatment response in acute psychosis from the Soteria project

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

Child development risk factors for adult schizophrenia in the British 1946 birth cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

Consensus development conference on antipsychotic drugs and obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

How frequent is chronic multiyear delusional activity and recovery in schizophrenia: a 20-year multi-follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

Antipsychotic dosing: how much but also how often?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

Neuroleptic withdrawal in schizophrenic patients. A review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

Executive function in schizophrenia: is it linked to psychosis and poor life functioning?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

A diagnostic interview: the schedule for affective disorders and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

Duration of untreated illness and outcome in schizophrenia: test of predictions in relation to relapse risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

Is executive impairment associated with schizophrenic syndromes? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

A systematic review of the effects of antipsychotic drugs on brain volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

A critique of the dopamine hypothesis of schizophrenia and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

21 January 2018

The Clinician's Illusion

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

A systematic review of longitudinal outcome studies of first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

Locus of control: relation to schizophrenia, to recovery, and to depression and psychosis -- A 15-year longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

Predictors of 10-year outcome of first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

Better pharmacotherapy for schizophrenia: what does the future hold?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

Recovery from psychotic illness: a 15- and 25-year international follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

Remission and recovery during the first outpatient year of the early course of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

A 10-year followup of remitting schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

The prediction of outcome in schizophrenia. I. Characteristics of outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

Long-term follow-up of patients hospitalized for schizophrenia, 1913 to 1940.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

"Breakthrough" dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

The Declaration of Helsinki and clinical trials: a focus on placebo-controlled trials in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

7 January 2021

Outcome in manic disorders. A naturalistic follow-up study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

7 January 2021

Long-term outcome of patients with schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

7 January 2021

Neurocognition as a stable endophenotype in bipolar disorder and schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

7 January 2021

Prognosis in schizophrenia. Prognostic predictors and outcome

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

7 January 2021

Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

7 January 2021

Follow-up study of formerly hospitalized voluntary psychiatric patients: the first two years

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

7 January 2021

Sustained remission in drug-free schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

7 January 2021

Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

7 January 2021

Posthospital Course and Outcome in Schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

7 January 2021

Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712000220

7 January 2021

10.1017/S0033291712000220

Identifiers

DOI

1 reference

31 July 2017

1 reference